Silicon Laboratories Inc. logo

Silicon Laboratories Inc. (SLAB)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
217. 47
-0.9
-0.4121%
$
7.19B Market Cap
- P/E Ratio
- Div Yield
355,800 Volume
-0.42 Eps
$ 218.37
Previous Close
Add Transaction
Day Range
217.3 218.27
Year Range
115.51 220.9
Want to track SLAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Silicon Laboratories (SLAB) Surpasses Q1 Earnings and Revenue Estimates

Silicon Laboratories (SLAB) Surpasses Q1 Earnings and Revenue Estimates

Silicon Laboratories (SLAB) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to a loss of $0.08 per share a year ago.

Zacks | 2 months ago
Genflow CEO on promising SLAB trial data - ICYMI

Genflow CEO on promising SLAB trial data - ICYMI

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO, Dr Eric Leire, talked with Proactive about encouraging results from the SLAB (Sarcopenia and Longevity in Aged Beagles) trial, highlighting sustained efficacy and safety following treatment. Leire explained that one of the most significant findings is the durability of the therapy's effects.

Proactiveinvestors | 3 months ago
Genflow reports sustained safety and efficacy three months after gene therapy dosing in dog trial

Genflow reports sustained safety and efficacy three months after gene therapy dosing in dog trial

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the European biotechnology company focused on gene therapies for age-related diseases, has reported that positive safety and efficacy signals from its SLAB trial have been maintained three months after the initial dosing period, with no adverse events observed. The SLAB (Sarcopenia and Longevity in Aged Beagles) trial is evaluating Genflow's proprietary SIRT6 centenarian gene therapy in aged dogs, targeting sarcopenia, the age-related loss of muscle mass and strength that also affects humans.

Proactiveinvestors | 3 months ago
All You Need to Know About Silicon Labs (SLAB) Rating Upgrade to Buy

All You Need to Know About Silicon Labs (SLAB) Rating Upgrade to Buy

Silicon Labs (SLAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 5 months ago
Silicon Laboratories Inc. (SLAB) M&A Call Transcript

Silicon Laboratories Inc. (SLAB) M&A Call Transcript

Silicon Laboratories Inc. (SLAB) M&A Call Transcript

Seekingalpha | 5 months ago
Texas Instruments to acquire Silicon Labs in $7.5B all-cash deal

Texas Instruments to acquire Silicon Labs in $7.5B all-cash deal

Texas Instruments Inc (NASDAQ:TXN) announced that it has agreed to acquire Silicon Laboratories (NASDAQ:SLAB) in an all-cash transaction valued at about $7.5 billion, expanding its presence in embedded wireless connectivity chips. Under the agreement, Silicon Labs shareholders will receive $231 per share in cash.

Proactiveinvestors | 5 months ago
Texas Instruments agrees to buy Silicon Labs for $7.5 billion.

Texas Instruments agrees to buy Silicon Labs for $7.5 billion.

Texas Instruments has agreed to buy Silicon Labs for $7.5 billion. The announcement has skyrocketed Silicon Labs' stock price by nearly 50% in intraday.

Youtube | 5 months ago
Silicon Laboratories (SLAB) Tops Q4 Earnings and Revenue Estimates

Silicon Laboratories (SLAB) Tops Q4 Earnings and Revenue Estimates

Silicon Laboratories (SLAB) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to a loss of $0.11 per share a year ago.

Zacks | 5 months ago
Texas Instruments in advanced talks to buy chip designer Silicon Laboratories, FT reports

Texas Instruments in advanced talks to buy chip designer Silicon Laboratories, FT reports

Texas Instruments is in advanced talks to buy chip designer Silicon Laboratories for about $7 billion, the Financial Times reported on Tuesday.

Reuters | 5 months ago
Silicon Labs Riding High On IoT Growth

Silicon Labs Riding High On IoT Growth

Silicon Labs is capitalizing on IoT market growth, gaining share in Bluetooth and Wi-Fi, and outperforming peers despite not benefiting from AI/data center hype. SLAB's near-term growth is driven by smart metering, healthcare monitoring, and electronic shelf labeling, with a robust $10B design win pipeline supporting long-term prospects. Margins are set to improve with Series 3 product adoption and potential channel restocking, while management targets 20% annual revenue growth and 20%-plus operating margins.

Seekingalpha | 5 months ago
Silicon Laboratories Inc. (SLAB) Presents at Barclays 23rd Annual Global Technology Conference Transcript

Silicon Laboratories Inc. (SLAB) Presents at Barclays 23rd Annual Global Technology Conference Transcript

Silicon Laboratories Inc. (SLAB) Presents at Barclays 23rd Annual Global Technology Conference Transcript

Seekingalpha | 7 months ago
Earnings Estimates Moving Higher for Silicon Labs (SLAB): Time to Buy?

Earnings Estimates Moving Higher for Silicon Labs (SLAB): Time to Buy?

Silicon Laboratories (SLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks | 7 months ago
Loading...
Load More